AU714316B2 - Novel alkylated (hetero)cyclic compounds, process for their preparation and the pharmaceutical compositions which contain them - Google Patents

Novel alkylated (hetero)cyclic compounds, process for their preparation and the pharmaceutical compositions which contain them Download PDF

Info

Publication number
AU714316B2
AU714316B2 AU40894/96A AU4089496A AU714316B2 AU 714316 B2 AU714316 B2 AU 714316B2 AU 40894/96 A AU40894/96 A AU 40894/96A AU 4089496 A AU4089496 A AU 4089496A AU 714316 B2 AU714316 B2 AU 714316B2
Authority
AU
Australia
Prior art keywords
formula
alkyl
substituted
cycloalkyl
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU40894/96A
Other languages
English (en)
Other versions
AU4089496A (en
Inventor
Philippe Delagrange
Patrick Depreux
Eric Fourmaintraux
Beatrice Guardiola-Lemaitre
Daniel Lesieur
Pierre Renard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Publication of AU4089496A publication Critical patent/AU4089496A/en
Application granted granted Critical
Publication of AU714316B2 publication Critical patent/AU714316B2/en
Assigned to LES LABORATOIRES SERVIER reassignment LES LABORATOIRES SERVIER Alteration of Name(s) in Register under S187 Assignors: ADIR ET COMPAGNIE
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/08—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/05—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/58—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Nutrition Science (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU40894/96A 1995-01-11 1996-01-09 Novel alkylated (hetero)cyclic compounds, process for their preparation and the pharmaceutical compositions which contain them Ceased AU714316B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9500238 1995-01-11
FR9500238A FR2729147A1 (fr) 1995-01-11 1995-01-11 Nouveaux composes (hetero) cycliques alkyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
AU4089496A AU4089496A (en) 1996-07-18
AU714316B2 true AU714316B2 (en) 1999-12-23

Family

ID=9475014

Family Applications (2)

Application Number Title Priority Date Filing Date
AU40893/96A Ceased AU694588B2 (en) 1995-01-11 1996-01-09 Novel alkylated (hetero)cyclic compounds, process for their preparation and the pharmaceutical compositions which contain them
AU40894/96A Ceased AU714316B2 (en) 1995-01-11 1996-01-09 Novel alkylated (hetero)cyclic compounds, process for their preparation and the pharmaceutical compositions which contain them

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU40893/96A Ceased AU694588B2 (en) 1995-01-11 1996-01-09 Novel alkylated (hetero)cyclic compounds, process for their preparation and the pharmaceutical compositions which contain them

Country Status (19)

Country Link
US (3) US5693665A (no)
EP (2) EP0721938B1 (no)
JP (2) JP3790289B2 (no)
CN (2) CN1067678C (no)
AT (2) ATE187438T1 (no)
AU (2) AU694588B2 (no)
CA (2) CA2167039C (no)
CY (1) CY2174B1 (no)
DE (2) DE69605452T2 (no)
DK (2) DK0721947T3 (no)
ES (2) ES2142550T3 (no)
FI (2) FI960124A (no)
FR (1) FR2729147A1 (no)
GR (2) GR3032174T3 (no)
HK (1) HK1013284A1 (no)
NO (2) NO312897B1 (no)
NZ (2) NZ280805A (no)
PT (1) PT721947E (no)
ZA (2) ZA96212B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996020925A1 (fr) * 1995-01-06 1996-07-11 Toray Industries, Inc. Derive heterocyclique benzocondense et son utilisation
US5753709A (en) * 1995-06-07 1998-05-19 Bristol-Myers Squibb Company N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
ATE275132T1 (de) * 1995-06-27 2004-09-15 Takeda Chemical Industries Ltd 4-acylamino(halogen)alkyl-chinolin derivate, deren herstellung und deren verwendung als melatonin-agonisten
AU6531296A (en) * 1995-07-26 1997-02-26 Takeda Chemical Industries Ltd. Benzocycloalkene compounds with melatonine receptor binding affinity, their production and use
FR2763335B1 (fr) * 1997-05-16 2000-11-24 Adir Nouveaux composes heterocycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP4569980B2 (ja) * 1997-08-07 2010-10-27 株式会社フジモト・コーポレーション 新規なエチルアミン誘導体
FR2771739B1 (fr) * 1997-11-28 2001-04-20 Adir Nouveaux composes naphtaleniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2772766B1 (fr) * 1997-12-24 2000-06-30 Adir Nouveaux composes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2784375B1 (fr) * 1998-10-12 2000-11-24 Adir Nouveaux derives cycliques a chaine cycloalkylenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2795323B1 (fr) * 1999-06-23 2001-11-16 Adir Utilisation de ligands melatoninergiques pour l'obtention de compositions pharmaceutiques destinees a la prevention ou au traitement des pathologies du systeme gastrointestinal
JP4877679B2 (ja) * 1999-09-03 2012-02-15 雪印種苗株式会社 植物成長調整剤
WO2004024707A2 (en) * 2002-09-16 2004-03-25 Abbott Laboratories Process for preparing amine type substituted benzofurans
US6822101B2 (en) 2002-09-16 2004-11-23 Abbott Laboratories Process for preparing amine-substituted benzofurans
FR2853649B1 (fr) * 2003-04-09 2006-07-14 Servier Lab Nouveaux derives d'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US7393865B2 (en) 2004-06-17 2008-07-01 Neurocrine Biosciences, Inc. Sleep inducing compounds and methods relating thereto
FR2942625B1 (fr) * 2009-03-02 2013-11-22 Centre Nat Rech Scient Derives indoliques pour le traitement de maladies neurodegeneratives
US11590663B2 (en) 2020-01-14 2023-02-28 International Business Machines Corporation Virtual reality enabled activity allocation
RU2750418C1 (ru) * 2020-11-20 2021-06-28 Виктор Владимирович Яснецов Средство, обладающее противогипоксической, антиамнестической и нейропротекторной активностью

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380750A (en) * 1991-08-13 1995-01-10 Adir Et Compagnie Arylethylamine compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3226402A (en) * 1965-12-28 And process of making and using same
US3407210A (en) * 1961-11-03 1968-10-22 Byk Gulden Lomberg Chem Fab Aminoethyl-benzofurans and derivatives thereof
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2680507B1 (fr) * 1991-08-23 1993-10-08 Adir Cie Nouvelles naphtylethylurees et naphtylethylthiourees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2689124A1 (fr) * 1992-03-27 1993-10-01 Adir Nouvelles naphtylalkylamines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380750A (en) * 1991-08-13 1995-01-10 Adir Et Compagnie Arylethylamine compounds

Also Published As

Publication number Publication date
NO960109L (no) 1996-07-12
NO960108L (no) 1996-07-12
PT721947E (pt) 2001-08-30
CA2167040A1 (fr) 1996-07-12
EP0721938B1 (fr) 1999-12-08
FI960124A0 (fi) 1996-01-10
JP3790289B2 (ja) 2006-06-28
ATE187438T1 (de) 1999-12-15
ATE199715T1 (de) 2001-03-15
FR2729147B1 (no) 1997-02-14
NO960108D0 (no) 1996-01-10
NZ280806A (en) 1996-09-25
NO312897B1 (no) 2002-07-15
ES2142550T3 (es) 2000-04-16
DE69612022T2 (de) 2001-09-20
US5703121A (en) 1997-12-30
NO313552B1 (no) 2002-10-21
AU4089496A (en) 1996-07-18
ZA96213B (en) 1996-07-26
EP0721947A1 (fr) 1996-07-17
CN1135480A (zh) 1996-11-13
DE69605452D1 (de) 2000-01-13
CN1067678C (zh) 2001-06-27
ES2157404T3 (es) 2001-08-16
NZ280805A (en) 1998-03-25
CA2167039C (fr) 2002-08-27
DE69612022D1 (de) 2001-04-19
GR3035789T3 (en) 2001-07-31
NO960109D0 (no) 1996-01-10
FI960124A (fi) 1996-07-12
CN1134938A (zh) 1996-11-06
US5693665A (en) 1997-12-02
FR2729147A1 (fr) 1996-07-12
ZA96212B (en) 1996-07-26
FI960123A0 (fi) 1996-01-10
CN1061653C (zh) 2001-02-07
HK1013284A1 (en) 1999-08-20
DK0721938T3 (da) 2000-05-29
CA2167040C (fr) 2001-05-08
EP0721938A1 (fr) 1996-07-17
CA2167039A1 (fr) 1996-07-12
US5780512A (en) 1998-07-14
DE69605452T2 (de) 2000-07-06
CY2174B1 (en) 2002-08-23
DK0721947T3 (da) 2001-04-17
GR3032174T3 (en) 2000-04-27
AU4089396A (en) 1996-07-18
AU694588B2 (en) 1998-07-23
JPH08231530A (ja) 1996-09-10
FI960123A (fi) 1996-07-12
JPH08239353A (ja) 1996-09-17
EP0721947B1 (fr) 2001-03-14

Similar Documents

Publication Publication Date Title
AU714316B2 (en) Novel alkylated (hetero)cyclic compounds, process for their preparation and the pharmaceutical compositions which contain them
AU703948B2 (en) New aryl(alkyl)propylamides, process for preparing them and pharmaceutical compositions containing them
US5843986A (en) Tricyclic amide compounds
AU704023B2 (en) New alkoxyaryl compounds, their processes of preparation and the pharmaceutical compositions which contain them
US6143789A (en) Naphthalene compounds
US20070191328A1 (en) Isoquinoline compounds
AU703998B2 (en) New arylalkyl(thio)carboxamides, processes for preparing them and pharmaceutical compositions containing them
AU755115B2 (en) New cyclic compounds having a cycloalkylene chain, a process for their preparation and pharmaceutical compositions containing them
AU704261B2 (en) Novel tricyclic amides, processes for their preparation and the pharmaceutical compositions which contain them
NZ556188A (en) New naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
US6071946A (en) Tricyclic urea compounds
US5998461A (en) Tricyclic amide compounds
AU1567699A (en) New tricyclic compounds, a process for their preparation and pharmaceutical compositions containing them
AU688965B2 (en) New O-arylmethyl-N-(thio)acylhydroxylamines, process for preparing them and pharmaceutical compositions containing them
WO1998052554A1 (en) Spirocyclopropyl fluorenes as melatonergic agents

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: LES LABORATOIRES SERVIER

Free format text: FORMER OWNER WAS: ADIR ET COMPAGNIE